Pipeline · Bill → Law
Step 1
Introduced
Jul 13, 2023
Step 2
Referred
Jul 14, 2023
E&C
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary
This bill requires the Food and Drug Administration (FDA) to issue guidance on the approval process for over-the-counter oral contraceptives so as to encourage drug manufacturers to submit applications for approval. The FDA must also evaluate (1) whether and to what extent consumers understand the labeling on oral contraceptives, and (2) whether the labeling could be improved.
Timeline · 3 actions
Jul 14, 2023
Referred to the Subcommittee on Health.
Jul 13, 2023
Introduced in House
Jul 13, 2023
Referred to the House Committee on Energy and Commerce.